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Congenital Myasthenic Syndrome Caused by
Decreased Agonist Binding Affinity Due to a
Mutation in the Acetylcholine Receptor e Subunit
Kinji Ohno,* Hai-Long Wang,† Margherita Milone,* of the synaptic response, and reconfirm the crucial role
of the e subunit in ACh binding.Nina Bren,† Joan M. Brengman,*
Satoshi Nakano,* Polly Quiram,†
Jerry N. Pruitt,* Steven M. Sine,† Results
and Andrew G. Engel*
*Muscle Research Laboratory Clinical Data
Department of Neurology Patient 1 of this communication was previously reported
†Receptor Biology Laboratory in a description of a syndrome attributed to abnormal
Department of Physiology and Biophysics interaction of acetylcholine (ACh) with AChR (Uchitel et
Mayo Foundation al., 1993). In brief, this woman, now 28 years old, had
Rochester, Minnesota 55905 moderately severe myasthenic symptoms since birth.
Studies of an intercostal muscle specimen at age 21
revealed normal end plate (EP) ultrastructure, normal
number of AChR per EP, and normal evoked quantalSummary
release, but very small miniature EP potentials (MEPPs).
Analysis of ACh-induced current noise was best fittedWe describe the genetic and kinetic defects for a low-
by a double Lorentzian, suggesting a kinetic abnormalityaffinity fast channel disease of the acetylcholine re-
of AChR or two populations of AChRs at the EPs (Uchitelceptor (AChR) that causes a myasthenic syndrome. In
et al., 1993). The parents, two siblings, and two childrentwo unrelated patients with very small miniature end
are unaffected. Patient 2, a 4 year-old boy, has also had
plate (EP) potentials, but with normal EP AChR density
myasthenic symptoms present since birth. His parents
and normal EP ultrastructure, patch-clamp studies
are unaffected, but a younger sister has elements of the
demonstrated infrequent AChR channel events, dimin-
same disease. Both patients had negative tests for
ished channel reopenings during ACh occupancy, and
anti-AChR antibodies and decremental compound mus-
resistance to desensitization by ACh. Each patient had
cle action potential responses on 2 Hz nerve stimula-
two heteroallelic AChR e subunit gene mutations: a
tion, and responded incompletely to anticholinesterase
common eP121L mutation, a signal peptide mutation
drugs.
(eG-8R) (patient 1), and a glycosylation consensus site
mutation (eS143L) (patient 2). AChR expression in HEK
Electrophysiologic and Morphologicfibroblasts was normal with eP121L but was markedly
Studies in Patient 2reduced with the other mutations. Therefore, eP121L
MEPPs were of such low amplitude that many weredefines the clinical phenotype. Studies of the engi-
lost in the baseline noise. Normally, d-tubocurarine isneered eP121L AChR revealed a markedly decreased
required to prevent muscle twitching during recordingrate of channel opening, little change in affinity of the
of end plate potentials (EPPs), but in the patient, EPPsresting state for ACh, but reduced affinity of the open
could be recorded in its absence. In this 4 year-oldchannel and desensitized states.
patient, the quantal content of the EPP (m) fell in the
lower range of values obtained in adult controls, but
was higher than in a 3 year-old control patient (Table
1). The amplitude of the MEPPs, calculated from theIntroduction
quantal component of the EPP (Elmqvist and Quastel,
1965), was markedly reduced (Table 1).Despite the smallIncreasing evidence supports the notion that a kinetic
abnormality of the acetylcholine receptor (AChR) in a amplitude of the MEPP, the number of end plate EP-
specific a-bungarotoxin (a-bgt)- binding sites was 5.2 3congenital myasthenic syndrome (CMS) predicts a mu-
tation in one or more AChR subunits (Engel, 1994b; Ohno 106 per EP. This value was higher than in a 3 year-old
control subject (4.7 3 106) but lower than in 13 adultet al., 1995a; Sine et al., 1995b). Thus, we showed that
prolonged activation of the AChR channel in the slow- controls (12.82 6 2.84 3 106; mean 6 SD). When EP
AChR was visualized in frozen sections with rhodamine-channel CMS is associated with mutations in the M2
and even the M1 transmembrane domains (Ohno et al., labeled a-bgt, the intensity of the fluorescent signal was
comparable with that observed at control EPs. Ultra-1995a; Ohno et al., 1995b; Ohno et al., 1996), or with a
mutation in the extracellular domain of the a subunit structural localization of AChR with peroxidase-labeled
a-bgt revealed a normal density and distribution ofthat increases the affinity of AChR for acetylcholine
(ACh) (Sine et al., 1995b). We now report discovery of AChR on the crests of the junctional folds (Figure 1),
and the AChR index (defined as the ratio of the lengtha mutation in the e subunit gene in two unrelated patients
that results in abnormally infrequent and brief episodes of the postsynaptic membrane reacting for AChR to the
length of the primary synaptic cleft [Engel, 1994a]) wasof channel activation. We show that these effects are
attributable to a decreased affinity of AChR for ACh, as 3.11 6 1.44 (mean 6 SE; 24 EP regions). This value is
close to the range of means obtained in five controlwell as a decreased rate of channel opening. Our find-
ings illustrate the importance of the affinity of AChR for subjects (3.13–3.31).
Ultrastructural examination of 30 regions of 14 EPsACh in governing both the efficiency and time course
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of openings were detected only in the presence of 50Table 1. Analysis of MEPPs and Quantal Content of EPP
mM ACh, whereas at normal EPs, such clusters appear
15 Adult Controls Patient 2
with ACh concentrations greater than 1 mM. The opening
ma 31 6 14 (190)b 22 6 7 (30) episodes were seldom interrupted by brief closures, so
MEPP Amplitude 1.00 6 0.32 (165) 0.067 6 0.031 (30)c that the major component of the burst open duration
(mV)
was not significantly longer than that of the open inter-
Values indicate mean 6 SD. Measurements at 298C 6 0.58C. Number vals, but was significantly shorter than the major compo-
of EPs are indicated in parentheses. nent of the burst open duration at control EPs (Figure
a Quantal content of EPP at 1 Hz stimulation corrected for a resting 2; Table 2). Channel events from the EP of the patient,
membrane potential of 280 mV, nonlinear summation, and non-
as in more than 99% of channel events at normal EPs,Poisson release.
had a conductance of ca. 60 pS. Approximately 7% ofb In a 3 year-old control patient m was 18 6 7 (18).
c Estimated by dividing the corrected EPP amplitude by m, and events at the EPs of the patient had a reduced conduc-
corrected for a fiber diameter of 50 mm. tance of ca. 46 pS and prolonged open durations typical
of AChRs containing the g instead of the e subunit (Mish-
ina et al., 1986). That the major ACh-evoked channel
showed no qualitative abnormality (Figure 1). Morpho-
events occurred at a reduced frequency,had abnormallymetric analysis of these EPs demonstrated normal post-
brief bursts of openings, and were resistant to clusteringsynaptic membrane density and normal synaptic vesicle
at high concentrations of ACh pointed to a kinetic defectdiameters (data not shown). The electrophysiologic and
in AChR.morphologic findings in patient 2, which were similar
to those previously reported in patient 1 (Uchitel et
al., 1993), suggested an abnormal interaction of AChR Mutational Analysis in Patient 1
with ACh.
In this patient, the very low MEPP amplitude without EP
AChR deficiency (Uchitel et al., 1993) prompted us toPatch-Clamp Analysis of EP AChR
search for a mutation in one or more AChR subunits.Channels in Patient 2
We first screened for mutations by single-strand confor-To search for a kinetic defect of AChR, we recorded
mation polymorphism (SSCP) analysis on PCR-ampli-single-channel currents from the EPs of the patient in
fied fragments of genomic DNA encoding the a, b, d,the presence of 50 nM to 50 mM ACh. Channel openings
and e subunits. We detected six aberrant conformers;were not detected at 50 nM ACh, were infrequent with
five were commonly observed even in normal controls,0.1 mM ACh, and were less frequent than normal with
but one was unique to patient 1. Direct sequencing of1 mM ACh (Figure 2). At 1 mM ACh, the channel open
the corresponding DNA fragments identified five hetero-intervals had a major component that was shorter than
zygous polymorphisms: a130–13insT in a intron 2;the major component of normal open intervals, and a
dG57A in d exon 2, causing no amino acid substitution;minor component of similar duration to that of the major
eC857115G in e intron 8; eC973–6T in e intron 9; andcomponent of normal open intervals (Table 2). Channel
eC1233T in e exon 11, causing no amino acid substi-open intervals, burst durations, and relative areas were
tution.essentially unaltered at ACh concentrations ranging
The aberrant conformer unique to patient 1 was duefrom 50 nM to 20 mM. At 50 mM ACh, the minor compo-
to a heterozygous C-to-T transition in e exon 5 at nucleo-nent of channel open intervals was absent. It was nota-
tide 362 (eC362T) that converted a proline to a leucineble that channel openings showed resistance to cluster-
codon at position 121 (eP121L) (Figure 3A). The altereding with increasing concentrations of ACh and clusters
proline is located in the extracellular domain of the e
subunit and is conserved across all subunits and spe-
cies (Figure 4).
To check for mutations that SSCP analysis might have
missed, we sequenced all exons and flanking intronic
regions of the a, b, d, and e subunits. This revealed
another heterozygous polymorphism, eG-8T in e exon
2, predicting an eG-3V substitution in the signal peptide
region, as well as a eG-24A mutation in e exon 1 that
converts a glycine to an arginine codon at position 28
(eG-8R) in the signal peptide region (Figure 3A). The
altered glycine at 28 is not conserved among the other
human subunits nor among the e subunits of other
species.
eP121L resulted in loss of a MspI restriction site. MspI
digestion of DNA samples obtained from family mem-
bers revealed that mother and son of patient 1 also carry
eP121L (Figure 3B). A search for eG-8R by allele-specific
PCR showed that the father and daughter of patient 1Figure 1. Ultrastructural Localization of EP AChR with Peroxidase-
are heterozygous for eG-8R (Figure 3B). Allele-specificLabeled a-bgt
PCR also established that patient 1 inherited the eG-3VThe density and distribution of AChR on the junctional folds is nor-
mal. Scale bar represents 1 mm. polymorphism from her mother (data not shown). Since
Myasthenic Syndrome Caused by AChR e-Subunit Mutation
159
Figure 2. Channel Events Elicited by 1 mM
ACh at a Control EP and at an EP of Pa-
tient 2
Channel openings (shown as upward deflec-
tions) are less frequent and the dominant
component of openings is briefer in the pa-
tient than in the control. Logarithmically
binned burst duration histograms are fitted
by the sum of exponentials. Time constant,
tn and relative areas, an, for each component
of bursts: Control: t1 5 0.05 ms, a1 5 0.14,
t2 5 3.24 ms, a2 5 0.88, total events, 1444.
Patient 2: t1 5 0.46 ms, a1 5 0.77, t2 5 2.1
ms, a2 5 0.23, total events, 2046. 280 mV, T
5 228C 6 0.58C.
the polymorphism and mutation of the signal peptide in mutation not only in patient 2, but also in his asymptom-
atic mother and symptomatic sister (Figure 3C) and al-patient 1 reside on different alleles, the polymorphism
does not contribute to the pathogenic effects of the lele-specific PCR demonstrated the eS143L mutation
in his asymptomatic father and his symptomatic sistermutation. Restriction analysis for eP121L and allele-spe-
cific PCR for eG-8R revealed no similar mutations in 100 (Figure 3C). eS143L was not found in 100 normal controls
or in 42 unrelated CMS patients.normal controls or in 42 unrelated CMS patients.
To summarize, both patients have two heterozygous
and heteroallelic e subunit gene mutations. Both pa-Mutational Analysis in Patient 2
In this patient, the patch-clamp evidence for a kinetic tients share eP121L; patient 1 also has a signal peptide
mutation (eG-8R) and patient 2 a glycosylation consen-defect in AChR, as well as the low MEPP amplitude
without EP AChR deficiency pointed to a mutation in an sus site mutation (eS143L). Therefore, we designed ex-
pression studies to determine the effects of the muta-AChR subunit. Since the low MEPP amplitude without
EP AChR deficiency was like that in patient 1, we first tions on the expression, ACh-binding affinity, and kinetic
properties of AChR.searched for eP121L detected in patient 1. Indeed, MspI
restriction analysis of genomic DNA in patient 2 con-
firmed that he also harbors a heterozygous eP121L mu-
tation. We then searched for a second mutation in the Expression Studies of Mutant e Subunits
Our molecular genetic analysis suggests that eP121Le subunit by sequencing all exons and adjacent intronic
regions of the e subunit gene. This revealed two hetero- plus either eG-8R or eS143L are required to produce
disease (Figure 3). To test this hypothesis further, wezygous polymorphisms (eC-60–70T, 70 bases upstream
from the first base of the translational start site, and engineered each mutation into the human e subunit and
coexpressed each with complementary a, b, and d sub-eA1245G in exon 11 causing no amino acid substitution),
as well as a second mutation. The second mutation was units in 293 HEK cells. As a control, we coexpressed
a, b, and d subunits in the absence of the e subunit.a heterozygous C-to-T transition at nucleotide 428 in e
exon 5 that converts a serine to a leucine codon at Measurements of 125I-a-bgt binding revealed robust ex-
pression of wild-type and eP121L AChRs, but reducedposition 143 (eS143L) (Figure 3A). The altered serine is
part of a consensus sequence for N-glycosylation at expression in the presence of eG-8R, eS143L, or in the
absence of the e subunit (Figure 5A).N141 (Gehle and Sumikawa, 1991) and is conserved
(Figure 4). The corresponding amino acid in the human b To determine whether the residual a-bgt binding in
the presence of eG-8R or eS143L can be accountedsubunit is threonine, which also signals for glycosylation
(Figure 4). for by a2bd2 pentamers, we measured ACh binding by
competition against the initial rate of 125I-a-bgt bindingRestriction analysis with MspI revealed the eP121L
Table 2. Open Intervals and Bursts of 60 pS Channels at Control End Plates and at End Plates of Patient 2
Open Intervals Bursts
Controls Patient 2 Controls Patient 2
t1 (ms) 0.07 6 0.02 0.38 6 0.04 0.09 6 0.03 0.45 6 0.04
Area 0.14 6 0.04 0.86 6 0.03 0.13 6 0.02 0.83 6 0.03
Number of EPs 7 7 7 7
t2 (ms) 1.13 6 0.10 1.69 6 0.14 2.99 6 0.26 2.48 6 0.50
Area 0.86 6 0.04 0.16 6 0.02 0.87 6 0.02 0.17 6 0.03
Number of EPs 7 6a 7 7
Values indicate means 6 SE. ACh concentration 5 1 mM. Potential 5 280 mV; T 5 228C 6 0.58C.
a The second and minor component of open intervals and bursts was not present at all patient EPs.
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Figure 4. Multiple Alignment of Part of the Extracellular Domains of
Muscle Nicotinic AChR
Proline 121 is strictly conserved in other human subunits and in the
e subunits of other species. Serine 143 is conserved in human a, d,
and g subunits, and in the e subunits of the other species. Boxes
enclose the conservedamino acids. Arrow indicates N-glycosylation
site at 141.
(Sine and Taylor, 1979). For a2bd2 pentamers, ACh bind-
ing is biphasic with a plateau at 50% occupancy ex-
tending over three decades of ACh concentration (Fig-
ure 5B). This biphasic profile is similar to that described
for mouse a2bd2 pentamers (Sine and Claudio, 1991),
and contrasts with that for a2bed pentamers that bind
ACh cooperatively (see Figure 8B). When eS143L is co-
transfected, ACh binding closely mimics that observed
with a, b, and d subunits alone, suggesting that all of
the a-bgt binding corresponds to a2bd2 pentamers (Fig-
ure 5B). When eG-8R is cotransfected, binding of ACh
is again biphasic, but the amplitude of the plateau is
reduced from 50% to approximately 25%. This asym-
metric profile for eG-8R is well described as the sum of
a monophasic profile similar to that of wild-type AChR,
plus a biphasic profile corresponding to a2bd2 pentam-
ers. These results suggest that the e subunit harboring
S143L does not assemble with a, b, and d subunits
to form pentamers, but the e subunit harboring G-8R
assembles, although with markedly reduced efficiency.
To determine whether e subunits containing G-8R or
eS143L can assemble with complementary subunits, we
studied their ability to oligomerize with the a subunit,
the earliest step in AChR assembly. We determined the
number of ae complexes from the number of curare-
Figure 3. Identification and Molecular Genetic Analysis of Mutations displaceable a-bgt sites in cells permeablized with sa-
in AChR e Subunits
ponin. The e subunit containing the glycosylation muta-
(A) Automated sequencing of e exon 5 around codon 121 in patient
tion, S143L, fails to assemble with the a subunit, as the1 (left panel), e exon 1 around codon 28 in patient 1 (middle panel),
number of specific a-bgt binding sites is indistinguish-and e exon 5 around codon 143 in patient 2 (right panel). The double
able from that observed in the presence of the a subunitpeaks showing heterozygous mutations are indicated by arrows.
The deduced amino acids are shown at the top. alone (Figure 5C). The e subunit containing the signal
(B) Upper panel: MspI restriction analysis of genomic DNA in the peptide mutation, G-8R, produces about 10% of the ae
family of patient 1. For the eP121L mutation, the wild-type allele complexes observed with wild-type e. Thus, e subunits
yields 77- and 109-bp fragments; the mutant allele gives rise to a
containing eG-8R or eS143L incorporate with reduced186-bp fragment. Both wild-type and mutant fragments are present
efficiency into surface AChRs owing to impaired associ-in patient 1 and in her asymptomatic mother and son. Lower panels:
ation with the a subunit. Therefore, in patients 1 and 2,Allele specific PCR demonstrates the eG-8R mutation in patient 1
and in her asymptomatic father and daughter. the predominant surface AChR is likely to contain the
(C) Upper panel: MspI restriction analysis of genomic DNA in the eP121L mutation.
family of patient 2. The eP121L mutation is present in patient 2, his
asymptomatic mother, and his symptomatic sister. Lower panels:
Comparison of EP and EngineeredAllele specific PCR demonstrates eS143L mutation in patient 2, his
eP121L AChRsasymptomatic father, and symptomatic sister.
To confirm pathogenicity of eP121L, we compared
single-channel currents recorded from EPs of patient 2
Myasthenic Syndrome Caused by AChR e-Subunit Mutation
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with those from 293 HEK cells transfected with either
wild-type or mutant human cDNAs. We chose a high
concentration of ACh for this comparison because the
essential defect in this syndrome is reduced response
to ACh despite normal density of AChR at the EP. At 50
mM ACh, the wild-type AChR activates in clusters of
openings, owing to repeated activation of a single chan-
nel, separated by prolonged closed periods due to de-
sensitization; within a cluster, the mean probability of
opening is high, 0.83 6 0.06. In contrast, AChRs from
both the patient EPs and HEK cells transfected with
eP121L open with low probability within clusters (Figure
6). For AChRs at the EP of patient 2, the mean open
probability within identified clusters is 0.081 6 0.02 at
50 mM ACh, while that for the engineered eP121L mutant
is 0.04 6 0.01 at 200 mM ACh. We found that the engi-
neered eP121L AChR required higher concentrations of
ACh to approach the open probability of the AChR at
the EP of the patient. Nevertheless, both the EP and
engineered mutant AChRs open with markedly reduced
efficiency.
Kinetic Steps in AChR Activation Affected
by eP121L
To identify the kinetic steps affected by eP121L, we
recorded single-channel currents over a range of ACh
concentrations from 293 HEK cells transfected with ei-
ther wild-type or mutant human cDNAs. As observed
for AChR from other species, the human wild-type AChR
opens in clusters of well defined activation episodes at
concentrations of ACh greater than 3 mM (Figure 7A).
By contrast, openings of the eP121L AChR appear as a
steady stream of events at 3 mM ACh, and show only
loose clustering at concentrations greater than 30 mM
(Figure 7B). Both the wild-type and mutant AChR exhibit
brief and long duration openings at 3 mM ACh, and only
long duration openings at saturating concentrations;
brief openings are visible as the component with a mean
duration of about 40 ms at 3 mM that is not present at
concentrations of 100 mM or greater (Figures 7A and 7B).
For the wild-type AChR, closed intervals within clusters
become progressively briefer with increasing ACh con-
centration, and at the highest concentrations approach
Figure 5. Expression of Mutant e Subunits the limit of resolution of the recording system (Figure
(A) Total a-bgt binding to intact HEK cells transfected with the indi- 7A). For the eP121L AChR, closed intervals within clus-
cated AChR cDNAs. The amount of bound 125I-a-bgt is normalized
ters also become briefer with increasing ACh concentra-to that measured for the wild-type human AChR (a2bed). Nonspecific
tion, but their mean duration approaches a limit of aboutbinding is that measured in the presence of 300 mM d-tubocurarine
10 ms (Figure 7B). These observations show that al-(a-bgt 1 curare, closed bars).
(B) Acetylcholine binding to intact cells transfected with the indi- though eP121L does not affect the stability of the open
cated AChR cDNAs determined by competition against the initial channel (i.e., mean open duration), it markedly impairs
rate of 125I-a-bgt binding. For a2bd2, the smooth curve is a fit to the both the rate of opening and the fraction of time spent
two site equation (Equation 2) with KA 5 9.6 3 1028, KB 5 1.5 3 1022, in the open state.and fractA 5 0.48. For abd 1 eS143L, the curve is a two site fit with
To describe quantitatively activation of wild-type andKA 5 1.7 3 1027, KB 5 1.2 3 1022, and fractA 5 0.43. For abd 1 eG-
mutant AChRs, we interpret the kinetics of channel8R, the curve is a weighted sum of the fit determined for a2bd2 plus
a component described by the Hill equation (Equation 1); the fitted opening and closing according to the following scheme
parameters are: Kov 5 7.6 3 1027, n 5 0.8, and the fraction of sites
corresponding to a2bd2 equals 0.47.
(C) Total a-bgt binding to saponin-permeabilized cells transfected
with the indicated pairs of AChRsubunit cDNAs or with the a subunit
alone. The amount of bound 125I-a-bgt is normalized to that mea-
sured for wild-type ae dimers. Nonspecific binding is that measured
in the presence of 300 mM d-tubocurarine (a-bgt 1 curare, closed
AR*1A A2R* ⇀↽
k1b
A2RB
k2b
⇀↽I I⇀↽
b1 a1
⇀↽
b2 a2
⇀↽
k11
A1R
k21
AR1A A2R⇀↽
k12
k22 (scheme 1)
bars).
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Figure 6. Comparison of Single Channel Cur-
rents from EP and Engineered eP121L AChRs
Clusters of single-channel currents elicited
by high concentrations of ACh are shown,
with openings upward deflections. Wild type
corresponds to the engineered adult human
AChR (a2bed) in the presence of 50 mM ACh,
eP121L to the engineered mutant AChR (a2b-
deP121L) in the presence of 200 mM ACh, and
EP to the AChR at an EP from patient 2 in the
presence of 50 mM ACh.
where two agonists A bind to the resting state of the analyze data for themutant AChR at ACh concentrations
below 30 mM owing to lack of clustering (see Experimen-receptorR with association rates k11 and k12 and dissoci-
ate with rates k21 and k22. Receptors occupied by one tal Procedures). Also, well-defined rate constants for
both sites could only be obtained by assuming equiva-agonist open with rate b1 and close with rate a1, while
receptors occupied by two agonists open with rate b2 lent binding sites for eP121L. Relaxing the constraint
of equivalent sites yielded similar parameters for theand close with rate a2. At high concentrations, ACh
blocks the open channel with forward rate k1b, and un- second binding step, but undefined parameters for the
first step (data not shown).Nevertheless thekinetic anal-blocks with rate k2b. To estimate each rate constant,
dwell times predicted by scheme 1 were fit by maximum ysis of eP121L reveals relatively small changes in rate
constants governing ACh binding to the resting state,likelihood to all of the data simultaneously; for each
type of AChR, this included open and closed durations but profound changes in channel gating.
Binding of ACh to the open state of the AChR can beobtained for the entire range of ACh concentrations. The
results of the fit, shown as smooth curves superimposed envisioned by connecting the singly and doubly occu-
pied open states in scheme 1 (dashed lines). Applyingonthe open and closed duration histograms, adequately
describe the kinetics of both wild-type and e121L AChR the principle of microscopic reversibility to the resulting
closed cycle, we obtain u1K2 5 u2K2*, where u1 and u2(Figure 7).
The fitting analysis establishes that eP121L markedly are the opening equilibrium constants of the singly and
doubly occupied states, and K2 and K2* are the dissocia-affects the kinetics of channel gating. Once doubly oc-
cupied, the wild-type AChR opens rapidly and effi- tion constants for ACh binding to the resting and open
states. Given u1, u2, and K2 estimated from kinetic analy-ciently, whereas the eP121L AChR opens with profound
latency and reduced efficiency (Figure 7); both opening sis, we calculate K2* for the wild-type AChR to be 35
nM, whereas that for the eP121L mutant is 1450 nMrate and open channel equilibrium constant are reduced
300- to 400-fold (Table 3). Opening of the singly occu- (Table 3). Thus, in addition to affecting channel gating,
eP121L reduces the affinity of ACh for the open channel.pied AChR, although slower than that of the doubly
occupied AChR, is slowed about 14-fold by eP121L (Ta-
ble 3). The effect of eP121L on gating is almost entirely
eP121L Reduces the Affinity of the AChR for AChconfined to the channel opening step, with little effect
Owing to its proximity to residues that contribute toon channel closing (Table 3).
binding of the competitive antagonists d-tubocurarineRates of association and dissociation of ACh are af-
and conotoxin M1 (residues 111 and 117; Figure 4; Sine,fected to a lesser extent by eP121L. For the human wild-
1993; Sine et al., 1995), eP121L might affect ACh affinitytype AChR, the rate of association is rapid and near the
by perturbing the contribution of the e subunit to thelimit of diffusion, as described for other species (Sine
binding site. Therefore, we sought direct evidence foret al., 1990; Zhang et al., 1995). Although slowed about
an effect of eP121L on the binding site.5-fold by eP121L, the rate of association is still fast
To examine the binding site in its simplest form, weenough to support rapid activation at the high concen-
coexpressed a and either wild-type or mutant e subunitstrations of ACh present at the synapse (Table 3). For the
and measured ACh binding to HEK cells permeabilizedhuman wild-type AChR, the rate of dissociation of ACh
with saponin. Oligomers of a and eP121L subunits bindfrom the second site is rapid, but that from the first
ACh with markedly reduced affinity (Figure 8A). Thus,site is slower (Table 3). The presence of eP121L slows
the interaction of eP121L with the a subunit is sufficientdissociation approximately 3-fold from the second site,
to reduce affinity for ACh; neither a fully assembledand has no detectable effect on dissociation from the
pentamer nor the presence of b and d subunits is re-first site. The resulting association and dissociation rate
quired.constants indicate that eP121L causes little change in
We then examined equilibrium binding of ACh to cellstheaffinity of ACh for the resting stateof theAChR (Table
transfected with either wild-type or mutant e subunits3). Error estimates for association and dissociation rate
plus complementary a, b, and d subunits. The fully as-constants were greater for the mutant than for the wild-
type AChR; presumably this resulted from inability to sembled human AChR binds ACh cooperatively and with
Myasthenic Syndrome Caused by AChR e-Subunit Mutation
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Figure 7. Kinetics of Activation of Human Wild-Type and eP121L AChRs
(A) Individual clusters of single-channel currents recorded from HEK cells expressing human wild-type AChR (a2bed) at the indicated ACh
concentrations at a bandwidth of 9 kHz (left column). Histograms of closed and open durations for each ACh concentration are shown with
the results of the fit to scheme 1 superimposed (center and right columns). The fitted rate constants are given in Table 3.
(B) Individual clusters of single-channel currents recorded from HEK cells expressing human mutant AChR (a2bdeP121L) at the indicated ACh
concentrations (left column). For the recording obtained at 3 mM ACh, openings do not cluster, so a representative segment of the recording
is shown. Histograms of closed and open durations for each ACh concentration are shown with the results of the fit to scheme 1 superimposed
(center and right columns). The fitted rate constants are given in Table 3. For the recording obtained at 3 mM ACh, the lack of clustering
prevented identification of a series of events corresponding to a single channel, so scheme 1 cannot be applied to these data. Instead, fits
to the sum of exponentials are presented (smooth curves) with the following time constants and relative areas: closed, t0 5 34 ms, a0 5 0.04,
t1 5 69 ms, a1 5 0.96; open, t0 5 39 ms, a0 5 0.49, t1 5 0.4 ms, a1 5 0.51; total events, 1058.
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Discussion
Our initial report of patient 1 postulated that the defect
of neuromuscular transmission was caused by an abnor-
mal interaction of ACh with its receptor (Uchitel et al.,
1993). This hypothesis was based on the reduced MEPP
amplitude without EP AChR deficiency, the normal size
of the synaptic vesicles, and the abnormal power spec-
trum of the ACh induced current noise. Patch-clamp
studies of EP AChRs in patient 2, who also has small
MEPPs without EP AChR deficiency, discovery of the
pathogenic mutations in both patients, and analysis of
the properties of the mutant AChRs in HEK cells confirm
the postulated disease mechanism.
Phenotype Effects of the Mutations
All three mutations are recessive, as each mutation is
present in an unaffected relative. eP121L, shared by
both patients, is near residues that affect ligand-binding
affinity (Sine, 1993; Sine et al., 1995a) and AChRs harbor-
ing this mutation are expressed in normal amounts in
HEK cells. Expression studies also suggest that eG-
8R, the signal peptide mutation found in patient 1, and
eS143L, the glycosylation consensus site mutation inFigure 8. eP121L Decreases Acetylcholine-Binding Affinity
patient 2, result in markedly reduced protein expression(A) Acetylcholine binding to saponin-permeabilizedcells transfected
with the indicated pairs of subunits determined by competition at the EP, or may even act as null mutations. These
against the initial rate of 125I-a-bgt binding. The curves are fits to findings predict that the clinical phenotype in both pa-
the Hill equation (Equation 1) with the following parameters: ae, Kov tients is defined by the consequences of eP121L mu-
5 2.45 3 1027, n 5 0.7; aeP121L, Kov 5 4.3 3 1026, n 5 0.7. tation.(B) Acetylcholine binding to intact cells transfected with the indi-
cated four subunits. For wild type (a2bed) the curve is a fit to Equation
1 with Kov 5 6.85 3 1027, and n 5 1.4. For mutant (a2bdeP121L), the Structural Interpretationcurve is a two-site fit (Equation 2) with KA 5 2.9 3 1026, KB 5 1.45 3
Mutagenesis, affinity labeling and expression studies1024, and fractA 5 0.5.
have established that the two ACh-binding sites of the(C) Acetylcholine binding to intact cells transfected with the indi-
cated four subunits in the presence of 100 mM proadifen. The curves adult AChR are formed by pairs of subunits, ad and ae.
are fits to Equation 2 with the following parameters: wild type (a2bde), The d and e subunits are required for maturation of the
KA 5 4.8 3 1029, KB 5 4.1 3 1028, fractA 5 0.5; mutant (a2bdeP121L), binding sites to produce high affinity for small ligands
KA 5 7.5 3 1029, KB 5 2.7 3 1026, fractA 5 0.5.
and selective binding of agonists and antagonists
(Blount and Merlie, 1989; Sine and Claudio, 1991). Stud-
micromolar affinity, as described for the adult mouse ies of the site-selective ligands, dimethyl-d-tubocura-
AChR (Sine et al., 1995). However, in the presence of rine (DMT) and conotoxin M1, identified three regions
eP121L, the ACh binding profile is markedly broadened, of the extracellular domain of the non-a subunits that
and is described as the sum of two components, one contribute to the binding site: N-terminal, predisulfide
with close to normal affinity and the other with markedly and postdisulfide regions (Sine 1993; Sine et al., 1995).
reduced affinity (Figure 8B). Thus, in the fully assembled The predisulfide region (containing residues 111 and
pentamer, eP121L appears to reduce the affinity of one 117 equivalent to those in the g and d subunits that
of the two binding sites for ACh. contribute to selective binding of DMT and conotoxin
Binding of ACh at equilibrium includes contributions M1) contains P121 and is likely to be affected by the
of resting, open channel and desensitized states of mutation (Figure 4). Although the predisulfide region is
AChR, each of which binds ACh with different affinity recognized to contribute to antagonist binding, the pres-
(for review, see Changeux, 1990). To examine binding ent results firmly establish its importance for agonist
to a single state, we measured ACh binding in the pres- binding as well. Both mutagenesis (Fu and Sine, 1994)
ence of a high concentration of the local anesthetic and photolabeling (Chiara and Cohen, 1992) studies
proadifen, which converts the AChR to the desensitized suggest that the predisulfide region is in close proximity
state (Weiland et al., 1977; Sine and Taylor, 1982). In the to the binding site. Owing to conformational restriction
presence of 100 mM proadifen, ACh binds to the wild- by its imino ring, proline at position 121 may orient the
type AChR with high affinity and with similar affinity for predisulfide region in a conformation essential for stabi-
the two binding sites (Figure 8C). Bycontrast, the eP121L lizing ACh in the binding site.
AChR exhibits a biphasic profile with one component
of normal affinity and the other with markedly reduced
affinity. Thus, when binding to the desensitized state is State-Specific Decrease in ACh Affinity by eP121L
The affinity of the AChR for ACh depends on its func-measured, the effect of eP121L is seen to be restricted
to one of the two binding sites where the affinity for ACh tional state (for review, see Changeux, 1990). ACh binds
to the resting state at concentrations in the range ofis reduced 65-fold.
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1024 M, whereas it binds to the open channel and desen- resemble those predominating at control EPs (Figure 2;
Table 2). The origin of these channel events cannot besitized states in the range of 1028 M (Table 3; Figure 8C).
determined with certainty but they likely reflect a lowThe resting state predominates in the absence of ACh,
level of expression of the e allele harboring S143L. Wewith its relatively low affinity still sufficient to bind ACh at
attribute the major component of EP channel eventsconcentrations of several hundred micromolar present
to AChRs containing eP121L because the engineeredduring synaptic activity. However, in the presence of
eP121L AChR shows robust expression and is kineticallyACh, high affinity binding to the open channel and de-
similar to the EP AChR. The kinetic similarities includesensitized states draws the AChR out of the stable rest-
infrequent channel events and diminished channel re-ing state, allowing these functional states to accumulate
openings during ACh occupancy caused by a decreasedin significant amounts (Jackson, 1989). Without the sta-
channel opening rate, and resistance to clustering atbilization provided by high affinity binding of ACh, the
high concentrations of ACh that suggests resistance toopen and desensitized states would occur with low
desensitization. In addition, the mean burst duration atprobability, as we observe for the eP121L AChR.
the EPs of patient 2 (0.45 ms; t1 in Table 2) is shorterThe decrease in ACh-binding affinity by eP121L is
than normal (2.99 ms; t2 in Table 2); presumably this isevident in the simplest form of the binding site, that of
due to the reduced opening rate in the patient and thusthe ae dimer, although the relationship of the dimer to
fewer reopenings during ACh occupancy. This differ-a particular functional state is not known. Our kinetic
ence in burst duration is paralleled in the expressionmeasurements on the fully assembled pentamer show
system where the mean burst duration for the mutantlittle change in affinity of the resting state for ACh, but
(0.7 ms, obtained from 1/a2; Table 3) is shorter than thatcalculations based on microscopic reversibility suggest
for wild type (2.0 ms, obtained from ([1 1 b2/k22]/a2;a 40-fold decrease in the affinity for the open-channel
Table 3). Quantitative differences between AChRs atstate. Thus, the low probability of opening of the eP121L
EPs of patient 2 and in the expression system may oweAChR owes to impaired stabilization of the open state
to differences in recording conditions (see Experimentalby ACh. By measuring binding to the high affinity desen-
Procedures).sitized state, we find a similar 65-fold decrease in affinity
of one of the two binding sites for ACh. Again, the re-
Effects of the eP121L Mutation
duced extent of desensitization of the eP121L AChR
on Neuromuscular Transmission
owes to inadequate stabilization of the desensitized
The eP121L mutation affects the safety margin of neuro-
state by ACh. Our overall results suggest that eP121L
muscular transmission primarily by reducing the synap-
decreases the affinity of one of the two binding sites for tic response to ACh quanta. Following release of ACh
ACh, presumably ae, and that the decrease is selective at the synapse, both binding sites of the mutant AChR
for functional states, open and desensitized. are likely to be doubly occupied because the concentra-
tion of ACh is high and the decrease in affinity of the
resting state for ACh is only about 2-fold. However, theImplications for AChR Activation
probability that a given occupancy will result in channelIn addition to affecting the affinity of functional states
opening depends on the rate of channel opening relativefor ACh, eP121L markedly slows the rate of channel
to the rate of ACh dissociation, or the ratio b2/k22. Ouropening (b2, Table 3). The rate of channel opening is a
kinetic analysis demonstrates a dramatic slowing of themeasure of the height of the free energy barrier in the
channel opening rate but little change in the rate of AChpathway toward opening, whereas the affinity for ACh
dissociation. Thus, b2/k22 is approximately 0.023 for theis a measure of the net change in free energy due to
eP121L mutant, whereas it is 3.3 for the normal AChRassociation and dissociation of ACh. We find similar
(Table 3). Thus, the markedly decreased MEPP ampli-changes in free energy of the two parameters: eP121L
tude is readily explained by a diminished number ofincreases free energy required for channel opening by
receptors being activated. Furthermore, the duration of3.6 kcal/mole, while it decreases free energy of ACh
the synaptic current is curtailed by the shorter thanbinding by 2.2 and 2.5 kcal/mole for the open and desen-
normal burst open duration.sitized states, respectively. The dual effect of eP121L
The properties of the eP121L mutation also have ther-on opening rate and ACh affinity suggests that the site
apeutic implications. They predict a favorable responseof ACh binding is closely coupled to the site that triggers
to 3,4-diaminopyridine, which increases the number ofchannel opening. Studies of the site-directed mutation
ACh quanta released by nerve impulse (Thomsen andaY190F also reveal a decreased rate of channel opening
Wilson, 1983) and thereby the number of postsynapticand a decrease in ACh binding affinity (Chenet al.,1995).
sites activated by ACh. Indeed, patient 1 has improvedThus, favorable contacts between ACh and its binding
significantly with this medication. Anticholinesterasesite appear to be an essential requirement for forming
drugs, which prolong the duration of the synaptic re-the transition state for channel opening.
sponse (Katz and Miledi, 1973), will also be beneficial,
and the resistance of the mutant AChR to desensitiza-
Properties of EP AChRs tion predicts that relatively high doses of these drugs
Patch-clamp studies in patient 2 enabled us to compare can be employed in clinical practice.
the properties of mutant AChRs at the EP with those of
engineered mutant AChRs expressed in HEK cells. In Comparison with Other Congenital
patient 2, the 60 pS EP channel events comprise a major Myasthenic Syndromes
and minor component (see arrows, Figure 2). The minor Clinical criteria, such as weakness increased by exertion
and a decremental response of the evoked compoundcomponent has open interval and burst durations that
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0 mV applied to the pipette. For all patches, the membrane potentialmuscle action potential, do not distinguish the present
was set to 280 mV; when possible, recordings were also obtainedsyndrome from other CMS. However, the eP121L muta-
at 240, 2120, and 2160 mV. Channel currents were recorded at 50tion is unique in that it leaves no anatomic footprint at
kHz using the Axopatch 200A amplifier (Axon Instruments), digitized
the EP. For example, the slow channel CMS (SCCMS) at 100 kHz, stored on hard disk, and analyzed using the program
causes an EP myopathy by cationic overloading, and MacTac (Instrutech) at a final bandwidth of 12 kHz. Burst durations
were determined by grouping openings separated by a specifiedCMS stemming from simple AChR deficiency show a
closed time that misclassifiesequal proportions of long closed timesdiminished density of AChR on the junctional folds (En-
within bursts and short closed intervals between bursts (Colquhoungel, 1994b). It is also noteworthy that SCCMS mutations
and Sakmann, 1985). Dwell time histograms were plotted on loga-prolong the burst open duration (Ohno et al., 1995a and
rithmic abscissa and fitted to the sum of exponentials by maximum
1995b; Sine et al., 1995b) whereas eP121L curtails it. likelihood (Sigworth and Sine, 1987).
Also, the SCCMS caused by the aG153S mutation is
associated with enhanced agonist binding affinity, in- mRNA and DNA Samples
mRNA was obtained using the Micro-FastTrack mRNA isolation kitcreased channel reopenings during ACh occupancy,
(Invitrogen). First-strand cDNA was prepared from mRNA by usingand increased desensitization of the mutant AChR by
random hexamer primers with the cDNA Cycle kit (Invitrogen) andACh (Sine et al., 1995b). By contrast, the eP121L muta-
by following the instructions of the manufacturer. Genomic DNA
tion results in diminished agonist binding affinity, re- was isolated from proteinase/SDS digest of blood or muscle by
duced channel reopenings during ACh occupancy, and phenol-chloroform extraction followed by ethanol precipitation
decreased desensitization of the mutant AChR by ACh. (Sambrook et al., 1989).
For these reasons, we propose the descriptive term of
PCR Procedureslow- affinity fast-channel syndrome for the present dis-
PCR primers for SSCP analysis and sequencing were prepared asorder. Finally, our study implies that mutations diminish-
previously described (Ohno et al., 1995a). The typical PCR reactioning agonist binding affinity may also occur in central
mixture included 60 mM Tris-HCl (pH 8.5), 15 mM (NH4)2SO4, 1.5 mM
ligand-gated channels and should spur the search for MgCl2, 0.25 mM each dNTP, 0.8 mM each primer, with 100 ng of
such mutations in neurologic and psychiatric disorders DNA and 1.25 U of Taq DNA polymerase (Boehringer Mannheim) in
50 ml. The typical cycling protocol consisted of denaturation at 948Cof unknown etiology.
for 2 min, 35 cycles of 948C for 30 s, 558C for 30 s, 728C for 3 min,
and final extension at 728C for 7 min.Experimental Procedures
We used allele-specific PCR to search for the eG-8R mutation,
detected in e-exon 1 in patient 1, and for the eS143L mutation,Muscle Specimens
detected in e-exon 5 in patient 2, in the patients’ relatives and normalIntercostal muscle specimens were obtained intact from origin to
controls. For the eG-8R mutation, the respective wild-type and mu-insertion from the patients and from control subjects without muscle
tant sense primers were 59-GGGTCCTGCTCCTCTaGG-39 and 59-disease undergoing thoracic surgery. All human studies were in
GGGTCCTGCTCCTCTaGA-39. Mismatched nucleotide ‘a’ was intro-accord with the guidelines of the Institutional Review Board of the
duced three nucleotides upstream to the 39 end of the primer toMayo Clinic.
avoid misannealing of the primer to the opposite allele. The anti-
sense primer was 59-GAAGTGGGATTTTTGGCTTA-39 in e subunitElectron Microscopy
gene intron 2. The expected PCR product had 467 bp. The PCRAn intercostal muscle specimen was used. EPs were localized and
procedure was optimized by adding 2.0 mM MgCl2 and 10% di-analyzed morphometrically by established methods (Engel, 1994a).
methyl sulfoxide.Peroxidase-labeled a-bgt was used for the ultrastructural localiza-
For the eS143L mutation, the respective wild-type and mutanttion of AChR (Engel et al., 1977).
sense primers were 59-TTCGATTGGCAGAACTGaTC-39 and 59-TTC
GATTGGCAGAACTGaTT-39, ‘a’ representing a deliberately mis-Intracellular Microelectrode Studies
matched nucleotide. The antisense primer was 59-GAAGCGGGTTTTAll studies were done at 228C 6 0.58C. MEPPs and EPPs were
TCTGAG-39 in e subunit gene intron 6. The expected PCR productrecorded as previously described (Engel et al., 1993). The number
had 473 bp. The standard PCR procedure was employed.of transmitter quanta released by nerve impulse (m) was determined
at 1 Hz stimulation by the variance method with correction for a
Exon Scanning by SSCP Analysisresting membrane potential of 280 mV, nonlinear summation, and
The “cold” SSCP procedure was employed (Hongyo et al., 1993)non-Poisson release (Elmqvist and Quastel, 1965; Martin, 1966;
with ca. 500 ng of PCR-amplified DNA. Denatured SSCP samplesLang et al., 1983). Due to their abnormally small amplitude, MEPPs
were loaded on 4%–20% gradient polyacrylamide gel, electropho-could not be recorded directly. Therefore, the MEPP amplitude for
resed at 128C, stained with ethidium bromide, and examined undera given EP was derived from the ratio of A/m, where A is the mean
ultraviolet light.EPP amplitude recorded from uncurarized muscle (Elmqvist and
Quastel, 1965). The value so obtained was further corrected for the
Sequence Analysissmaller than adult size of the muscle fibers of the patient (29 mm
PCR-amplified fragments of genomic DNA or cDNA were purifiedversus 50 mm) (Katz and Thesleff, 1957).
by Wizard PCR Preps (Promega). Plasmids were purified by QIAwell
8 Plus Plasmid kit (Qiagen). DNA fragments and plasmids wereCounts of AChR per EP in Patient 2
sequenced with an Applied Biosystems model 373A DNA sequencerThe number of AChRs per EP was measured with 125I-labeled a-bgt,
using fluorescently labeled dideoxy terminators.as previously described (Engel et al., 1993).
Patch-Clamp Recordings from EP AChRs Restriction Enzyme Analysis
A 211 bp fragment of genomic DNA spanning the eP121L mutationThese were performed in the cell-attached mode by a slight modifi-
cation of the previously described method (Milone et al., 1994). The was amplified with primers 59-TGCAAAAAGCTCGGTTTC-39 and
59-GGCCTCGGAGTAGCTCTT-39. The PCR product (25 ml) was puri-bath and pipette solutions contained 135 mM NaCl, 5 mM KCl, 2
mM CaCl2, 1 mM MgCl2, 15 mM NaHCO3, 1.3 mM Na2HPO4, 11.1 fied by ethanol precipitation. Restriction enzyme digestion was car-
ried out by incubating the purified PCR product, 2 ml of 10 3 reactionmM dextrose (pH 7.2) with the pipette solution containing specified
concentrationsof ACh.Owing to trauma induced by microdissection buffer and 5 U MspI (Boehringer-Mannheim), in a volume of 20 ml
at 378C for 2 hr. The products were size-fractionated on 4% agaroseof single-muscle fibers, we obtained a null resting potential. This
was confirmed by the absence of detectable channel events with gel containing ethidium bromide.
Neuron
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Cloning of Human b- and e-Subunit cDNAs Sequencing of our e clone revealed no mutation or polymorphism
when compared with our controls and to the reference sequencecDNA for the normal human b subunit was cloned from a nested
RT-PCR product amplified from normal muscle. The first primers of human e subunit gene (GenBankaccession number X66403, mod-
ified from Beeson et al., 1993). Therefore, we assume that our clonefor amplification were 59-GGCGAGCCGCCAGCGTATGA-39 (nucleo-
tides 285 through 266) and 59-AAGAGGCAGAGAAGGATAGG-39 has the consensus sequence.
(nucleotides 1503 through 1522); the nested primers were 59-cggccg
gaattcATGACCCCAGGGGCTCTG-39 (nucleotides 269 through Construction of Human Wild-Type and Mutant AChR
252) and 59-cggccggaattcGGCTTGACAGTATCACCAAACT-39 (nu- cDNAs and Expression in 293 HEK Cells
cleotides 1482 through 1503), the artificial lower case sequences Human a and d subunit cDNAs were provided by Dr. Jon Lindstrom
serving to introduce EcoRI sites into the PCR product. The nested (Schoepfer et al., 1988; Luther et al., 1989). The b and e subunit
PCR product spanned nucleotides -69 through 1504, whereas the cDNAs were cloned from normal human skeletal muscle as de-
coding region of the b subunit extends from 269 to 1434. The nested scribed above. All four cDNAs were subcloned into the CMV-based
PCR product was precipitated with ethanol, digested with EcoRI, expression vector pRBG4 (Lee et al. 1991) for expression in 293
gel-purified, and then ligated in pBluescript II SK(2) (Stratagene) HEK cells. The eP121L and eS143L mutations were constructed by
using a DNA Ligation Kit (PanVera). Since the b subunit cDNA cloned bridging restriction sites with synthetic double stranded oligonucle-
in this manner failed to express in HEK cells, we introduced the otide harboring the mutations. For eP121L, a 64 bp oligonucleotide
Kozak sequence for the b subunit gene 59 to nucleotide 269 by the bridged from an AccI to a BstEII site, whereas for eS143L, a 105 bp
megaprimer method (Kozak, 1987; Uppender et al., 1995), using oligonucleotide bridged from an FspI to an AccI site. The presence
cloned Pfu DNA polymerase (Stratagene). For the first round of PCR, of each mutation and the absence of unwanted mutations was con-
the template was the cloned b subunit cDNA; the primers consisted firmed by dideoxysequencing. The eG-8R mutation was constructed
of the 59-GGAAACAGCTATGACCATG-39 generic primer for M13 and by overlap PCR; the final amplified fragment was ligated between
59-CAGCAGAGCCCCTGGGGTCATAGCCTGGCGgaattcctgcagccc a PstI site in the poly linker of pRBG4 and a Bsu36I site within the
gggggatc-39, where the underlined nucleotides represent the Kozak e cDNA, and was sequenced in its entirety. Human embryonic kidney
sequence of the b subunit gene and the lower case sequence is fibroblast cells (293 HEK) were transfected with mutant or wild-
part of the pBluescript II SK(2) multiple cloning site. The amplified type AChR subunit cDNAs using calcium phosphate precipitation
156-bp fragment contained part of the plasmid multiple cloning site, as described (Bouzat et al., 1994).
the Kozak sequence, and the first 21 nucleotides of the b subunit
gene coding region. For the second round of PCR, the megaprimer
Patch-Clamp Recordings from AChRs Expressed in HEK Cells
was 3 ng of the purified product of the first run of PCR and the
Recordings were obtained in the cell-attached configuration (Hamill
template consisted of the cloned b subunit excised from the plasmid
et al., 1981) at a membrane potential of 270 mV and a temperaturewith EcoRI. The second round of PCR consisted of 10 cycles per-
of 228C (Bouzat et al., 1994). The bath and pipette solutions con-formed with the megaprimer as the only primer and 25 additional
tained 142 mM KCl, 5.4 mM NaCl, 1.8 mM CaCl2, 1.7 mM MgCl2, 10cycles in the additional presence of 40 pmoles each of the M13
mM HEPES (pH 7.4). Single channel currents were recorded usinggeneric primer and 59-cggccggaattcGGCTTGACAGTATCACCAA
an Axopatch 200A at a bandwidth of 50 kHz, digitized with a PCMACT-39 (nucleotides 1482 through 1503), the artificial lower case
adapter at 94 kHz (VR-10B, Instrutech Corporation), transferred tosequence serving to introduce the EcoRI sites into the PCR product.
a Macintosh computer using the program Acquire (Instrutech Corpo-The second PCR product was cut by EcoRI, ligated into pBluescript
ration), and detected by the half-amplitude threshold criterion usingII SK(2), and then transferred to the pRBG4 expression vector (Lee
the program MacTac (Instrutech Corporation) at a final bandwidthet al., 1991).
of 9 kHz. Open and closed duration histograms were constructedWe sequenced our b clone and compared it with the reference
using a logarithmic abscissa and square root ordinate (Sigworthsequence of thehuman b subunit gene (GenBank accession number
and Sine, 1987), and fitted to the sum of exponentials by maximumX14830, modified from Beeson et al., 1989) and with cDNA and DNA
likelihood. For kinetic analysis according to scheme 1, clusters ofof our human controls. Comparison with the reference sequence
openings corresponding to a single channel were identified as arevealed 3 discordant nucleotides in the coding region (G instead
series of closely spaced events preceded and followed by closedC at position 227, indicating an alanine instead of a proline at codon
intervals greater than a specified duration; this duration was taken29; G instead A at position 26, indicating a glycine instead of a
as the point of intersection of the predominant closed time compo-glutamate at codon 9; and T instead of A at position 560 indicating
nent in the histogram and the succeeding closed time component.an isoleucine instead of an asparagine at codon 187), as well as 3
Clusters were then examined for homogeneity in terms of opendiscordant nucleotides in the 39 untranslated region (insertion of a
probability and mean open duration; clusters within two standardC at position 1456, and deletion of GA at positions 1478–1479).
deviations of the mean for each parameter were accepted for furtherDirect sequencing of both cDNA and genomic DNA from 18–20
analysis. For wild type, greater than 90% of clusters were accepted,human controls indicated nucleotides identical to those in our clone
while for the eP121L AChR all clusters were accepted. Finally, clus-and no polymorphisms at positions 227, 560, 1456, 1478, and 1479.
ters with greater than 10 events for wild type and greater than twoHowever, 26G in our b subunit clone proved to be a common poly-
events for eP121L were accepted. Once identified, the clusters ofmorphism, being detected in 17 out of 60 alleles by BsaJI restriction
open and closed intervals were entered into a table, transferred toanalysis.
an IBM RS6000 computer, and analyzed according to scheme 1The first PCR primers for amplification of the e subunit were 59-
using an interval-based maximum likelihood method that incorpo-CACGCAGCAGGATGGCAAGG-39 (nucleotides 271 through 252)
rated corrections for missed events (Qin et al., 1996). Single channeland 59-TGGAAGACTGGCACCTGAGA-39 (nucleotides 1631 through
dwell times, obtained from single patches at several concentrations1650); the nested PCR primers were 59-cggccggaattcATGGCAA
of ACh, were fitted simultaneously. For wild-type AChR, concentra-GGGCTCCGCTT-39 (nucleotides 260 through 243) and 59-cggccg
tions of ACh used for analysis and events analyzed were: 3 mMgaattcCAGGGGGAAGGGATCATAAT-39 (nucleotides 1499 through
(2576 events, 45 clusters), 5 mM (3401 events, 84 clusters), 10 mM1518), the lower case sequences comprising the EcoRI site. The
(4133 events, 37 clusters), 30 mM (4051 events, 42 clusters), 50 mMPCR reaction mixture contained 1.25 units of cloned Pfu DNA poly-
(3516 events, 102 clusters), and 100 mM (2091 events, 37 clusters).merase, 10% dimethyl sulfoxide, and Pfu buffer (Stratagene) in 50 ml.
For the eP121L mutant, concentrations used for analysis and eventsThe first PCR was carried out by denaturation at 948C for 2 min
analyzed were:30 mM (960 events, 34 clusters), 100mM (1071 events,followed by 25 cycles of 948C for 30 s, 558C for 30 s, and 728C for
23 clusters), 200mM (2050 events, 15 clusters), 300 mM (1731 events,90 s. The nested PCR was carried out under identical conditions
23 clusters), and 1000 mM (1821 events, 17 clusters). A uniform filterbut the denaturation step was followed by 30 cycles of amplification.
bandwidth of 9 kHz and a dead time of 25 ms were imposed for allThe nested PCR product spanned nucleotides 260 through 1518
recordings. After fitting, error estimates for each parameter wereof the e subunit gene, whereas the coding region of the e subunit
determined as described (Qin et al., 1996). Open and closed durationextends from nucleotides 260 through 1419. The second PCR prod-
histograms were calculated from the fitted rate constants and super-uct was cut by EcoRI, ligated into pBluescript II SK(2), and then
transferred to the pRBG4 expression vector (Lee et al., 1991). imposed on the experimental dwell time histograms.
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ACh Binding Measurements Bouzat, C., Bren, N., and Sine, S.M. (1994). Structural basis of the
different gating kinetics of fetal and adult acetylcholine receptors.Three days after transfection, intact HEK cells were harvested by
gentle agitation in phosphate buffered saline (PBS) plus 5 mM EDTA. Neuron 13, 1395–1402.
We added 1 mM esterase inhibitor diisopropylphosphofluoridate to Changeux, J.P. (1990). Functional architecture and dynamics of the
the PBS/EDTA solution, and cells were incubated for 15 min. Cells nicotinic acetylcholine receptor: an allosteric ligand gated channel.
were briefly centrifuged, resuspended in high potassium Ringer’s In Fida Research Foundation Neuroscience Award Lectures, Volume
solution, and divided into aliquots for measurementsof ACh binding. 4 (New York: Raven Press), pp. 21–168.
High potassium Ringer’s solution contains 140 mM KCl, 5.4 mM
Chen, J., Zhang, Y., Akk, G., Sine, S., and Auerbach, A. (1995).NaCl, 1.8 mM CaCl2, 1.7 mM MgCl2, 25 mM HEPES, 30 mg/liter Activation kinetics of recombinant mouse nicotinic acetylcholinebovineserum albumin, adjusted to pH 7.4 with 10 mM–11 mM NaOH.
receptors: mutations of a subunit tyrosine 190 affect both bindingSpecified concentrations of ACh were added 30 min prior to addition
and gating. Biophys. J. 69, 849–859.of 125I-labeled-a-bgt (5 nM), which was allowed to bind for 30 min
Chiara, D., and Cohen, J. (1992). Identification of amino acids con-to occupy approximately half of the surface receptors. Binding of
tributing to high and low affinity d-tubocurarine sites on the Torpedo125I-a-bgt was stopped by adding potassium Ringer’s solution con-
nicotinic acetylcholine receptor subunits. Biophys. J. 61, A106.taining 300 mM d-tubocurarine, followed by filtration using a cell
harvester (Brandel Incorporated). Radioactivity retained by the glass Colquhoun, D., and Sakmann, B. (1985). Fast events in single-chan-
fiber filters (Whatman GF-B, 1 mm cutoff) was measured with a nel currents activated by acetylcholine and its analogues at the frog
gamma counter. Binding properties of ae dimers were determined muscle end plate. J. Physiol. (Lond.) 369, 501–557.
in cells permeabilized with saponin by modification of the method Elmqvist, D., and Quastel, D.M.J. (1965). A quantitative study of end-
of Blount and Merlie (1991). After removing the growth medium, plate potentials in isolated human muscle. J. Physiol. (Lond.) 178,
cells were incubated for 5 min in PBS/EDTA plus 0.1% BSA and 505–529.
0.5% saponin. Following addition of high potassium Ringer’s solu-
Engel, A.G. (1994a). Quantitative morphological studies of muscle.tion, cells were briefly centrifuged, resuspended in high potassium
In Myology: Basic and Clinical, Second Edition A.G. Engel and C.Ringer’s solution, and divided into aliquots for ACh-binding mea-
Franzini-Armstrong, eds. (New York: McGraw-Hill), pp. 1018–1045.surements. The total number of binding sites was determined by
Engel, A.G. (1994b). Myasthenic syndromes. In Myology, Secondincubating cells for 1 hr in the presence of 5 nM 125I-labeled-a-bgt.
Edition, A.G. Engel and C. Franzini-Armstrong, eds. (New York:Nonspecific binding was determined in the presence of 300 mM d-
McGraw-Hill), pp. 1798–1835.tubocurarine. The initial rate of 125I-a-bgt binding was determined
to yield fractional occupancy of sites by ACh (Sine and Taylor, 1979). Engel, A.G., Lindstrom, J.M., Lambert, E.H., and Lennon, V.A. (1977).
Competition measurements were analyzed according to either the Ultrastructural localization of the acetylcholine receptor in myasthe-
monophasic Hill equation (Equation 1) or the sum of two distinct nia gravis and in its experimental autoimmune model. Neurology
binding sites (Equation 2): 27, 307–315.
Engel, A.G., Nagel, A., Walls, T.J., Harper, C.M., and Waisburg, H.A.
1-Y 5 1/(1 1 ([ACh]/Kov)n) (1) (1993). Congenital myasthenic syndromes: I. Deficiency and short
open-time of the acetylcholine receptor. Muscle. Nerve. 16, 1284–
1-Y 5 fractA(1/(1 1 [ACh]/KA) 1 (1-fractA)(1/(1 1 [ACh]/KB) (2) 1292.
Fu, D.-X., and Sine, S.M. (1994). Competitive antagonists bridge thewhereY is fractional occupancy by ACh,Kov is an overall dissociation
a-g subunit interface of the acetylcholine receptor through quater-constant for a monophasic binding profile, KA and KB are intrinsic
nary ammonium-aromatic interactions. J. Biol. Chem. 269, 26152–dissociation constants for two binding sites, and fractA is the fraction
26157.of sites with dissociation constant KA.
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